CLOSURE Medical Receives Medical Design Excellence Award
14 April 2004 - 5:06AM
PR Newswire (US)
CLOSURE Medical Receives Medical Design Excellence Award RALEIGH,
N.C., April 13 /PRNewswire-FirstCall/ -- CLOSURE Medical
Corporation , a global leader in biomaterial-based medical devices,
announced today that it has received a Medical Design Excellence
Award from Canon Communications, the publisher of Medical Device
& Diagnostic Industry Journal, for its design of the DERMABOND
ProPen XL Applicator System. (Photo:
http://www.newscom.com/cgi-bin/prnh/20040413/LATU072) The DERMABOND
ProPen XL Applicator System provides physicians with greater
precision application and control of adhesive flow utilizing the
High- Viscosity DERMABOND Topical Skin Adhesive. The device is a
disposable, sterile, single-use medical delivery system, which is
used by healthcare professionals as a replacement for sutures and
staples when closing incisions and lacerations. All DERMABOND
products are distributed by ETHICON, INC., a Johnson & Johnson
Company. The Medical Design Excellence Awards competition is the
only awards program that exclusively recognizes contributions and
advances in the design of medical products. Products are evaluated
on design and engineering features incorporating innovative use of
materials, user-related features that improve healthcare delivery
and change traditional medical attitudes or practices, features
that provide enhanced benefits to the patient and the ability of
the product development team to overcome design and engineering
challenges so the product meets its clinical objectives. A
comprehensive review of the entries was performed by an impartial,
multidisciplinary panel of third-party judges with expertise in
biomedical engineering, human factors, industrial design, medicine,
diagnostics, and medical packaging. "We are honored to be
recognized by the Medical Design Excellence Awards for the
DERMABOND ProPen XL Applicator System," said William M. Cotter,
Vice President of Operations and Project Leader for ProPen XL. "We
are dedicated to developing and manufacturing products that fulfill
the unmet needs of healthcare providers and patients and feel that
the ProPen XL product has greatly enhanced the ease of use for
physicians and practitioners." The 2004 Medical Design Excellence
Award recipients will be honored at a ceremony during the Medical
Design & Manufacturing East 2004 Conference and Exposition,
June 15-17, 2004 at New York City's Jacob K. Javits Convention
Center. Gold and Silver award recipients will be announced at this
time. About CLOSURE Medical Corporation CLOSURE Medical Corporation
is a global leader in the development and manufacture of innovative
biomaterial-based medical devices that fulfill the needs of
healthcare practitioners, patients and consumers. For additional
information on CLOSURE Medical visit its website at
http://www.closuremed.com/ or visit the "Clients" section of the
Allen & Caron website at http://www.allencaron.com/. This
release contains certain forward-looking statements which involve
known and unknown risks, delays, uncertainties or other factors not
under the Company's control which may cause actual results,
performance or achievements of the Company to be materially
different from the results, performance, or other expectations
implied by these forward-looking statements. These factors include,
but are not limited to the early stage of commercialization of the
Company's products; the progress of its research and development
programs for future products; the need for regulatory approval and
effects of governmental regulation; technological uncertainties;
the satisfactory conclusion of negotiations with, and dependence on
marketing partners, and dependence on patents and trade secrets, as
well as those detailed in the Company's Annual Report on Form 10-K
for the year ended December 31, 2003, filed with the Securities and
Exchange Commission. Although the Company believes that the
expectations in the forward-looking statements are reasonable, the
Company cannot guarantee such results. The Company undertakes no
obligation to publicly revise these forward-looking statements to
reflect events or circumstances that arise after the date hereof.
http://www.newscom.com/cgi-bin/prnh/20040413/LATU072 DATASOURCE:
CLOSURE Medical Corporation CONTACT: investors, Joe Allen,
+1-212-691-8087, , or media, Len Hall, +1-949-474-4300, , both of
Allen & Caron Inc for CLOSURE Medical Corporation; or Benny
Ward, CFO of CLOSURE Medical Corporation, +1-919-876-7800 Web site:
http://www.allencaron.com/ Web site: http://www.closuremed.com/
Copyright
Closure Medical (NASDAQ:CLSR)
Historical Stock Chart
From Aug 2024 to Sep 2024
Closure Medical (NASDAQ:CLSR)
Historical Stock Chart
From Sep 2023 to Sep 2024
Real-Time news about Closure Medical (MM) (NASDAQ): 0 recent articles
More Closure Medical (MM) News Articles